Literature DB >> 32960649

Cognitive-behavioral therapy and buprenorphine for opioid use disorder: A systematic review and meta-analysis of randomized controlled trials.

Virgil Lee Gregory1, Rebecca J Bartlett Ellis2.   

Abstract

Background: Recent systematic reviews have questioned the ability of psychosocial intervention to add substantive benefit to buprenorphine therapy.
Objectives: The purpose of the present meta-analysis was to test the random effects model (REM) null hypothesis that, for opioid use disorder (OUD) and opioid biological sample outcomes, the summary effect of cognitive-behavioral therapy (CBT) + buprenorphine randomized controlled trials (RCTs) = 0.
Methods: A systematic review was conducted searching electronic databases and the reference lists of included studies. The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) criteria were used to guide this review and the REM meta-analysis.
Results: The initial meta-analytic model (k = 4) was insignificant (REM Hedges' g =.22, Z = 1.27, p =.206, 95% CI: -0.12-0.56) and heterogeneous (I2 = 53.47). A pre-specified categorical moderator analysis explained the heterogeneity via CBT modality. Categorical moderator analysis (k = 4) showed non-individual CBT RCTs (k = 2) to have a REM Hedges' g summary effect of.598 (p =.006) and individual-CBT RCTs (k = 2) to have a REM Hedges' g summary effect of -0.010 (p = .936). The difference between these two subgroups was significant (Q = 5.85, df = 1, p = .016).
Conclusion: The evidence cautiously suggests that for OUD, there may be some benefit to adding non-individual CBT to buprenorphine therapy.

Entities:  

Keywords:  Cognitive-behavioral therapy; RCT; buprenorphine; medication; meta-analysis; opioid use disorder

Year:  2020        PMID: 32960649     DOI: 10.1080/00952990.2020.1780602

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  4 in total

1.  Management of opioid use disorder, opioid withdrawal, and opioid overdose prevention in hospitalized adults: A systematic review of existing guidelines.

Authors:  Susan L Calcaterra; Richard Bottner; Marlene Martin; Honora Englander; Zoe M Weinstein; Melissa B Weimer; Eugene Lambert; Matthew V Ronan; Sergio Huerta; Tauheed Zaman; Monish Ullal; Alyssa F Peterkin; Kristine Torres-Lockhart; Megan Buresh; Meghan T O'Brien; Hannah Snyder; Shoshana J Herzig
Journal:  J Hosp Med       Date:  2022-07-26       Impact factor: 2.899

2.  Effectiveness of medication for opioid use disorders in transition-age youth: A systematic review.

Authors:  Sara J Becker; Kelli Scott; Sarah A Helseth; Kristin J Danko; Ethan M Balk; Ian J Saldanha; Gaelen P Adam; Dale W Steele
Journal:  J Subst Abuse Treat       Date:  2021-05-29

Review 3.  Opioid Use Disorder: Treatments and Barriers.

Authors:  Karan Patel; Sean Bunachita; Ank A Agarwal; Aaron Lyon; Urvish K Patel
Journal:  Cureus       Date:  2021-02-06

4.  Comparative benefits of social housing and buprenorphine on wheel running depressed by morphine withdrawal in rats.

Authors:  Jonah D Stickney; Michael M Morgan
Journal:  Psychopharmacology (Berl)       Date:  2021-07-10       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.